Text Size
1 study found for:    NCT01179217

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Active, not recruiting A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Conditions: Sickle Cell Anemia;   Sickle ß0-Thalassemia
Interventions: Drug: L-glutamine;   Drug: 100% maltodextrin
To Top

† Indicates status has not been verified in more than two years